SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Femta Pharmaceuticals Announces IND Filing of FM101, a Novel Monoclonal Antibody Targeting IL-6 with Potent Anti-Inflammatory Activity